Xtant Medical Holdings, Inc.
XTNT · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $117 | $91 | $58 | $55 |
| % Growth | 28.4% | 57.5% | 4.9% | – |
| Cost of Goods Sold | $49 | $36 | $26 | $23 |
| Gross Profit | $68 | $55 | $32 | $32 |
| % Margin | 58.2% | 60.8% | 55.4% | 58.8% |
| R&D Expenses | $2 | $1 | $1 | $1 |
| G&A Expenses | $29 | $26 | $15 | $14 |
| SG&A Expenses | $78 | $64 | $38 | $35 |
| Sales & Mktg Exp. | $49 | $38 | $23 | $21 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80 | $66 | $39 | $36 |
| Operating Income | -$12 | -$10 | -$7 | -$4 |
| % Margin | -10.3% | -11.1% | -11.7% | -7% |
| Other Income/Exp. Net | -$4 | $9 | -$2 | -$1 |
| Pre-Tax Income | -$16 | -$1 | -$8 | -$5 |
| Tax Expense | $0 | -$2 | $0 | $0 |
| Net Income | -$16 | $1 | -$8 | -$5 |
| % Margin | -14% | 0.7% | -14.6% | -8.8% |
| EPS | -0.12 | 0.006 | -0.09 | -0.057 |
| % Growth | -2,281.8% | 106.1% | -59.1% | – |
| EPS Diluted | -0.12 | 0.005 | -0.09 | -0.057 |
| Weighted Avg Shares Out | 134 | 119 | 94 | 85 |
| Weighted Avg Shares Out Dil | 134 | 127 | 94 | 85 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $3 | $2 | $1 |
| Depreciation & Amortization | $4 | $3 | $1 | $1 |
| EBITDA | -$8 | $5 | -$5 | -$3 |
| % Margin | -6.7% | 5.6% | -9.4% | -4.5% |